Comments

Regenxbio Stock Price, Quotes and Forecasts

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RGNXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.93

0.263.90%

Pre-Market: 8:22 AM EDT

Q4 2024 Earnings in 14 days from now on Thu Mar 13th, after the market close

Regenxbio (RGNX) Forecast

News Earnings Regenxbio (RGNX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Regenxbio Stock Price, Quotes and Forecasts | NASDAQ:RGNX | Benzinga

Explore Regenxbio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGNX.

Open	-
Close	-
Volume / Avg.	1.91K / 1.23M
Day Range	- - -
52 Wk Range	6.44 - 28.80
Market Cap	$343.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	16.91%
Days to Cover	8.74

Recent News

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns

Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and declining appeal in retinal diseases.

Vandana Singh

Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With REGENXBIO Shares Monday?

REGENXBIO stock is trading higher on Monday after the company reached a critical point in its trial for Duchenne gene therapy.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	1.91K / 1.23M
Day Range	- - -
52 Wk Range	6.44 - 28.80
Market Cap	$343.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	16.91%
Days to Cover	8.74

About Regenxbio Inc

Sector

Health Care

Industry

Biotechnology

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: Celcuity (NASDAQ:CELC), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE), Olema Pharmaceuticals (NASDAQ:OLMA) and Ironwood Pharmaceuticals (NASDAQ:IRWD).

What is the forecast, or price target, for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $35.40.

What is the current price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $6.93 last updated February 27, 2025 at 8:22 AM EST.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.